DPP4 inhibitors can not only improve respiratory diseases [20], such as acute respiratory distress syndrome [21] and ILDs [22], but also cardiovascular diseases [23], such as left heart dysfunction [24] and atherosclerosis [25]. This evidence concerns the gene DPP4 and respiratory system disorder.